肺力咳口服液联合复方异丙托溴铵雾化吸入 治疗儿童支气管肺炎的临床效果
CSTR:
作者:
作者单位:

作者简介:

杨一明,男,主治医师,主要研究方向是小儿呼吸系统疾病。

通讯作者:

中图分类号:

R 563.1+ 2

基金项目:


Clinical Effect of Feilike Oral liquid Combined with Compound Ipratropium Bromide for Aerosol Inhalation in the Treatment of Children with Bronchial Pneumonia
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    摘 要目的:探讨肺力咳口服液联合复方异丙托溴铵雾化吸入在儿童支气管肺炎治疗中的应用效果。 方法:选取 2021 年 1 月至 2022 年 12 月瑞金市人民医院收治的 60 例支气管肺炎患儿,采用随机数字法将其分为观察组(31 例)和对 照组(29 例)。对照组患儿使用复方异丙托溴铵吸入治疗,观察组患儿在对照组基础上使用肺力咳口服液治疗,观察并比 较两组患儿的临床疗效、症状缓解时间、肺功能指标[第 1 秒用力呼气容积(FEV1)、最大呼气流量(PEF)、最大中期 呼气流量(MMEF)]、血气指标[动脉氧分压(PaO2)、二氧化碳分压(PaCO2)、氧饱和度(SaO2)]、血清炎症因子、 不良反应发生率。 结果:观察组患儿治疗总有效率为 93.55 %,较对照组的 79.31 % 高,差异具有统计学意义(P < 0.05); 观察组患儿的咳嗽、气促、肺部啰音及发热等症状缓解时间均较对照组短,差异具有统计学意义(P < 0.05);治疗后两 组患儿 FEV1、PEF、MMEF 水平均较治疗前升高,且治疗后观察组患儿 FEV1、PEF、MMEF 水平均较对照组高,差异具 有统计学意义(P < 0.05);治疗后两组患儿 PaCO2 水平均较治疗前下降,PaO2、SaO2 水平均较治疗前提高,且治疗后观 察组患儿 PaCO2 水平较对照组低,PaO2、SaO2 水平均较对照组高,差异具有统计学意义(P < 0.05);治疗后两组患儿肿 瘤坏死因子 –α(TNF–α)、C 反应蛋白(CRP)、白细胞介素 –4(IL–4)水平均较治疗前下降,且治疗后观察组患儿 TNF–α、 CRP、IL–4 水平均较对照组低,差异具有统计学意义(P < 0.05);两组患儿不良反应发生率比较,差异无统计学意义 (P > 0.05)。 结论:肺力咳口服液联合复方异丙托溴铵雾化吸入在儿童支气管肺炎治疗中疗效较好,在改善症状、炎症情况、 肺功能以及血气指标方面更具优势,并具有安全性。

    Abstract:

    AbstractObjective To explore the curative effect of Feilike oral liquid combined with compound ipratropium bromide for aerosol inhalation in children with bronchial pneumonia. Methods A total of 60 children with bronchial pneumonia admitted to Ruijin People's Hospital were enrolled between January 2021 and December 2022. According to random number method, they were divided into an observation group (31 cases) and a control group (29 cases). The control group was treated with compound ipratropium bromide for aerosol inhalation, while the observation group was addiitonally treated with Feilike oral liquid on the basic of the control group. The clinical curative effect, symptoms remission time, pulmonary function indexes [forced expiratory volume in first second (FEV1), peak expiratory flow (PEF), maximal mid–expiratory flow curve (MMEF)], blood gas indexes [partial pressure of oxygen (PaO2), partial pressure of carbon dioxide in artery (PaCO2), arterial oxygen saturation (SaO2)], serum inflammatory factors and incidence of adverse reactions in the two groups were observed and compared. Results The total response rate of treatment in the observation group was higher than that in the control group (93.55 % vs 79.31 %) (P < 0.05). The remission time of symptoms (cough, shortness of breath, lung rales, fever) in the observation group were shorter than those in the control group (P < 0.05). After treatment, FEV1, PEF and MMEF in the two groups were increased, which were higher in the observation group than those in the control group (P < 0.05). After treatment, PaCO2 was decreased in the two groups, which was lower in the observation group than that in the control group, while PaO2 and SaO2 were increased, which were higher in the observation group than those in the control group (P < 0.05). After treatment, the serum levels of tumor necrosis factor-α (TNF-α), C-reactionprotein (CRP) and interleukin-4 (IL-4) in the two groups were decreased, which were lower in the observation group than those in the control group (P < 0.05). There was no significant difference in the incidence of adverse reactions between the two groups (P > 0.05). Conclusion The curative effect of Feilike oral liquid combined with compound ipratropium bromide for aerosol inhalation is good in children with bronchial pneumonia, which has more advantages in terms of improving symptoms, inflammation, pulmonary function and blood gas indexes, and has certain safety.

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2023-08-23
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2024-02-23
  • 出版日期:
文章二维码
特别声明

近期有不法分子冒充我刊名义给作者打电话或发邮件,编造各种理由要求添加微信或QQ、伪造复制我刊编辑部公章发放假冒录用通知书等等各种方式试图骗取作者钱财。为强化编辑部工作规范,加强单位公章管理,维护作者的正当权益和财产利益, 我刊在此郑重声明:(1)编辑部与作者沟通方式为电话和邮件,在本刊唯一官方网站(http:/szzxyjhzz.szrch.com)“联系我们”下拉菜单,或者网站最下端信息栏可以查询),绝对不会要求作者添加微信或QQ。 (2)自2025年2月1日起,注销废除“深圳中西医结合杂志编辑部”电子公章;我刊稿件录用通知调整为加盖编辑部实体公章的纸质文件或其扫描件,录用稿件仅收取合理版面制作费和审稿费,收款单位为“深圳市第二人民医院”对公账户,其他加盖电子公章或涉及私人账户者均为伪造假冒。望广大作者提高警惕,谨防上当受骗。 《深圳中西医结合杂志》编辑部

关闭